Computational Drug Discovery

Computational Drug Discovery

Computational Drug Discovery

Editor-in-Chief: Maria Kontoyianni, Ph.D
Title Abbreviation: Comput. Drug Discov.
ISSN: Request Pending
Frequency: One Volume per year
Publisher: Publishing House of Sciences
Contact: info@phosciences.com


Aims & Scope of the Journal

Computational Drug Discovery is an international, peer-reviewed journal intended to publish high-quality manuscripts that focus on research pertaining to computational approaches in areas of chemistry and biology toward lead and drug discovery. Besides the traditional core subject of computational and theoretical chemistry, the journal features computational methodologies applied to organic and medicinal chemistry, biology, biochemistry, bioinformatics, cheminformatics, and metabolism. This open-access journal also brings cutting-edge investigations in a broad range of research including, but not limited to, cross-disciplinary topics such as bioorganic chemistry, biotechnology, rational drug design and target discovery.

Computational Drug Discovery encourages submission of manuscripts on multidisciplinary topics at the interface of theory and other scientific fields describing advances and major progress within the realm of computations and drug development. Furthermore, review articles, commentaries, highlights of critical work reported in other journals, book reviews, correspondence, and perspectives on the future in the field will also be included.

The journal is committed to publishing original research and reviews on a broad range of topics through a rigorous review process for a wide spectrum of computational scientists involved in all aspects of drug discovery. It also offers authors the commitment of high standards of production and accelerated publications.


Submission & Peer Review Policy

  • All submissions must be original and containing new insights and results that are not published nor being considered for publication elsewhere.
  • The publication of submitted manuscripts is subject to editorial prescreening and peer review.
  • Authors may also suggest potential reviewers who are familiar with the technical aspect of their paper.
  • At least two expert opinions will be collected for each manuscript.
  • Final decision on any paper is made by the Editor-in-Chief.